drugset / Trial / NCT05620901

DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

NCT05620901

Phase 0 Completed 15 enrolled Lejla Vajzovic, MD, FASRS
RandomizedParallel-groupOpen-labelTreatment

Summary

The Tender Study is a prospective, open-label, single-center, randomized, investigator-initiated clinical study seeks to investigate the safety and efficacy of the DEXTENZA insert in pediatric patients following retinal surgery or laser treatment under anesthesia.

Timeline

Start
2023-02-01
Primary completion
2025-02-11
Completion
2025-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Comparator Prednisolone Other / unclassified 1 % Topical